This group was established in 2010 at the Faculty of Pharmacy with the mission of providing general and specialized education in the fields of nanotechnology, life sciences, and pharmaceutical sciences. Its aim is to advance understanding and practical application of these disciplines in pharmacy.

The group initially started with six faculty members from the Faculty of Pharmacy: Dr. Hamid Akbari Joor, Dr. Mohammad Raoufi, Dr. Rasoul Dinarvand, and Dr. Morteza Mahmoudi, under the management of Dr. Fatemeh Atyabi. The expertise of the faculty members spans related fields such as pharmaceutics, pharmacology, cellular and molecular biology, chemical and materials engineering. They have numerous publications in high-impact international journals and hold several patents registered in the United States. Many projects undertaken by this group have received support from national organizations and committees.

Pharmaceutical nanotechnology is an interdisciplinary field aimed at education and research to advance knowledge and technology in various aspects of medical and pharmaceutical sciences. Its primary focus includes the diagnosis and treatment of diseases and the repair of tissues and organs at the molecular scale within the body. Nanotechnology enables novel applications or enhances existing properties of materials by introducing new characteristics or improving existing ones. This is achieved through the integration of pharmaceutical sciences, engineering, chemistry, biomaterials, cellular and molecular biology, and other fundamental sciences.

The outcomes of these studies include the development and application of engineered nanodevices and nanostructures for constructing, controlling, tracking, treating, and repairing tissues and cells, as well as creating new or regenerating damaged tissues.

The group’s activities focus on two main areas:

1. Designing innovative targeted drug delivery systems for disease diagnosis and treatment, with an emphasis on drugs used in cancer diagnosis and therapy.
2. Developing tissue engineering and regenerative systems using biomaterials and polymers.

Numerous research projects addressing national research priorities are conducted in a specialized laboratory equipped for this purpose, with funding from both domestic and international sources.

Becoming a research hub by acquiring the latest technologies in related fields, enhancing specialized expertise for conducting dynamic, science-generating research activities, and establishing effective international collaborations for training leading researchers in the specialized domain.

Attracting human resources in the fields of education and research.

Carrying out large-scale, collaborative research projects in alignment with national health, wellness, and therapeutic priorities.

Achieving expertise in the technology of producing pharmaceutical nanostructures.